Академический Документы
Профессиональный Документы
Культура Документы
trysin
reaction
Keyphrases:
R. delemar Iipase #{149}a-chymodetermination of glycerol by coupled enzymatic
#{149}
thin-layer chromatography
#{149}
AutoAnalyzer
#{149}
476
Calbiochem,
of the chemical
procedures.
It would be simple and
specific.
Errors
or losses possible
in more complex
techniques
would be minimized
if prior treatment
of
the sample was not required
and if the complete
determination
was performed
in a single reaction
vessel.
We have developed
a simple,
precise,
and reproducible
procedure
that links the enzymatic
hydrolysis of serum triglycerides
to the simultaneous
enzymatic determination
of glycerol.
In our opinion,
the
self-evident
advantages
of the new technique
render
it the method
of choice for the assay of serum triglycerides.
Materials
Apparatus
A Model DBG Spectrophotometer
(Beckman
Instruments,
Inc., Fullerton,
Calif. 92634),
a Model
2000 Spectrophotometer
(Gilford
Instruments,
Inc.,
Oberlin,
Ohio 44704) and a Model 330 Spectrophotometer
(G. K. Turner
Assoc.,
Palo Alto,
Calif.
94303) were used for the spectrophotometric
assays.
A single-channel
AutoAnalyzer
Sampler
II System
(Technicon
Instrument
Corp.,
Tarrytown,
N. Y.
10591) with a Model 111 Fluorometer
(G. K. Turner
Assoc.) was used for the automated
determination
of
serum triglycerides.
Matched
Pyrex cuvets (Calbiochem, La Jolla, Calif. 92037) were used for all spectrophotometric
readings
at 340 nm. Oxford Samplers
(Calbiochem)
were used in all assays.
Chemicals
Calbiochem
products
used were: a-Chymotrypsin
(peptidylpeptide
hydrolase;
EC 3.4.4.5),
elastase
(pancreato-peptidase
E; EC 3.4.4.7),
glycerol kinase
(ATP: glycerol
phosphotransferase;
EC
2.7.1.30),
lactate
dehydrogenase
(L-lactate : NAD oxidoreductase; EC 1.1.1.27),
lipase (glycerol
ester hydrolase;
EC 3.1.1.3) from hog pancreas
(Pronase),
pyruvate
kinase
(ATP: pyruvate
phosphotransferase;
EC
2.7.1.40),
trypsin
( peptidylpeptide
hydrolase;
EC
3.4.4.4),
adenosine-5-diphosphate
(ADP),
adenosine-5-triphosphate
(ATP),
bovine serum albumin,
L-a-glycerophOSphate,
lecithin,
linolenic
acid, lysolecithin,
methyl
linoleate,
methyl
linolenate,
methyl
oleate,
reduced
nicotinamide
adenine
dinucleotide
(NADH),
oleic acid, P-enolpyruvate
(PEP),
and tnolein. 1,3-Diolein
was purchased
from Applied
Sciences Laboratory,
Inc., State College, Pa. 16801. Lipases (glycerol
ester hydrolase;
EC 3.1.1.3) from R.
delemar,
A. niger and G. candidum
were products
of
Miles Laboratories,
Inc., Kankakee,
Ill. 60901. All
other chemicals
were either
Analytical
Reagent
or
the otherwise
best available
grade.
Samples
of serum were obtained
from hospital
and
commercial
laboratories
and from donors.
All samples and pooled sera were assayed,
subdivided,
and
maintained
frozen or lyophilized
until needed. In our
experience
(to be reported
in a future
communication) triglycerides
in serum
are stable under these
conditions.
Glycerol
ADP
glycerol
kinase
pyruvate
kinaoe
ATP
glycerol-i-P
#{247}
PEP
-.
lactate
Pyruvate
+ NADH
ATP
ADP
#{247}
pyruvate
dehydrogenaae
-
Lactate
NAD
The decrease
in absorbance
at 340 nm is proportional to the concentration
of glycerol.
The glycerol assay reagent contains,
in a final volume of 3 ml: 5 mol
of magnesium,
0.9 mol
of ATP,
0.9 zmol of PEP, 6 U of pyruvate
kinase, 2 U of lactate dehydrogenase,
NADH to a final absorbance
at
340 nm of 0.9-1.0
(approx.
0.4 mg) in potassium
phosphate
buffer (pH 7, 0.1 mol/liter).
The triglyceride
reagent
has the same composition
as the glycerol reagent;
per assay, it contains
additionally
400 U of R. delemar
lipase, 30 U of a-chymotrypsin,
and 5 mg of bovine serum albumin.
A glycerol kinase solution
containing
2 U in 50 zl
is prepared
by diluting
the enzyme
in potassium
phosphate
buffer (pH 7, 0.1 mol/liter)
containing
0.1
g of bovine serum albumin
per 100 ml.
The glycerol
and the triglycerides
reagents
have
proven to be stable for at least one year in dry form
in the refrigerator
(Triglycerides
and Glycerol
StatPack,
Calbiochem,
La Jolla, Calif. 92037). After re-
constitution
with water and storage at 4#{176}C,
these reagents can be used for at least 24 h.
The same glycerol reagent is used for the enzymatic determination
of glycerol after alkaline
hydrolysis,
but the final volume of the reagent
is 2.5 ml instead
of 3 ml. The following additional
reagents
are needed
for the alkaline hydrolysis:
Potassium
hydroxide,
approx.
0.7 mol/liter.
Dissolve 4 g of potassium
hydroxide
in 10 ml distilled
water. When cool, dilute to 100 ml with ethanol.
Magnesium
sulfate,
approx.
0.18 mol/liter.
Dissolve 2.17 g of anhydrous
magnesium
sulfate
in
water and dilute to 100 ml.
Free GyceroI
in Serum
1. To 3 ml of glycerol
reagent
in a cuvet with a
10-mm light path, add 0.2 ml of serum.
Mix. Incubate for about 5 mm at 30#{176}C,
to consume
endogenous substrates.
2. Read the absorbance
(A0) at 340 nm, with distilled water as a blank. Add 50 l of the glycerol kinase solution,
mix, and incubate
at 30#{176}C.
3. Read the absorbance
of the sample 10 mm (A10)
after the addition
of glycerol kinase.
Obtain iXA by subtracting
A10 from Ao.
Calculations:
M x 23.7 = mg glycerol in 100 ml
of serum;
LA x 228 = mg glycerol
in 100 ml of
serum, expressed
as triolein.
Triglycerides
in Serum
A. Enzymatic
hydrolysis.
1. To 3 ml of triglycerides reagent
in a cuvet with a 10-mm light path, add
50 cl of serum,
mix, and incubate
at 30#{176}C
for about
10mm.
2. Read the absorbance
(A0) of the sample
at 340
nm, with distilled
water as a blank.
Add 50 l of
glycerol kinase, mix, and incubate
at 30#{176}C.
3. Read the absorbance
at 340 nm 10 mm (A10)
after the addition
of glycerol kinase.
4. Obtain &4 by subtracting
A10 from A0.
5. Calculations:
.A
X 883 = mg triglycerides
in
100 ml of serum, expressed
as triolein.
B. Alkaline
hydrolysis.
1. Into a screw-capped
culture tube, pipet 0.2 ml of serum and 0.5 ml of potassium hydroxide
solution,
mix, cap the tube and place
it in a water bath at 60#{176}-70#{176}C
for 30 mm. Cool to
room temperature.
2. Add 1 ml of magnesium
sulfate
solution,
mix,
and centrifuge.
Use the clear supernatant
fluid in the
following assay.
3. To 2.5 ml of the glycerol reagent in a cuvet with
a 10-mm light path, add 0.5 ml of supernatant
fluid
(from step 2), incubate
for 5 mm at 30#{176}C,
and read
the absorbance
(A0) of the sample
at 340 nm, with
distilled water as a blank.
4. Add 50 tl of glycerol kinase solution.
Mix and
incubate
at 30#{176}C.
Read the absorbance
10 mm (A10)
after the addition
of glycerol kinase.
5. Obtain A
by subtractingA1o
from Ao.
6. Calculations:
Corrected
M x 738 = mg triglycerides in 100 ml of serum, as triolein.
CLINICAL CHEMISTRY, Vol. 19. No. 5, 1973
477
Chromatography
Chloroform:methanol
(2:1 by vol) was used to
extract
the lipids from incubation
mixtures
(8). The
solvent was evaporated
at low temperature
(less than
40#{176}C)
under a stream
of nitrogen.
The residue
was
dissolved
in a volume of chloroform:methanol
(2:1)
equivalent
to one-tenth
the original
volume
of the
serum.
Standard
solutions
were prepared
to contain
10 g of triglycerides
(or equivalent
weight of other
compounds)
per liter. A 5-l sample of each solution
was applied
to an Eastman
Kodak
Silica Gel No.
6060 Chromagram,
1 cm above the bottom edge. The
ascending
chromatogram
was developed
(9, 10) in
diethyl
ether: benzene: ethanol: acetic
acid (40:50: 2:0.2) until the solvent front had reached
a height of
4 cm above the point of sample application.
The chromatogram
was then
dried
and developed
in the
same direction
in hexane:diethyl
ether:acetic
acid
(180:30:2).
The spots were made visible by exposure
to iodine vapors in a closed tank.
Evaluation
of Lipases
Lipases
were evaluated
by one or more of the following procedures:
1. Titration
of fatty acids liberated
from an emulsion of olive oil (11). Units of lipase are expressed
as
microequivalents
of fatty acid liberated
per minute
by this procedure
at 30#{176}C.
2. Determination
of the glycerol liberated
by various amounts
of lipase from the same olive oil emulsion (11). The reaction
was stopped
at selected
times
by adding
an equal volume of trichloroacetic
acid, 5
g in 100 ml of water. The acid and the unreacted
olive oil were removed
by extracting
twice with four
volumes
of chloroform
and once with four volumes of
diethyl
ether. The last traces of ether were removed
by bubbling
nitrogen
through
the solution.
This
treatment
left a clear aqueous
solution
containing
glycerol in amounts
proportional
to the extent of hydrolysis.
Glycerol
was determined
in a suitable
frac478
GLYCEROL
(AS
IRIOLEIN)
mq
No addition
a-Chymotrypsin
Elastase
Pronase
Trypsin
S
IS
IS
25
25
UNITS
Fig. 1. Production
by R. delemar lipase,
of glycerol
30
35
40
45
Percent
hydrolysis
Amount
30-40%
100%
90%
98%
73%
30 U
15 U
90 P.U.K. units
5000 N.F. units
54
OF LIPASEPERASSAY
s-chymotrypsin
other
proteases-such
as elastase
(15 U), trypsin
(5000 N.F.
units)
(18), and Pronase
(90 PUK
units)
(19)-were
substituted
for a-chymotrypsin
(Table
1). Because
of the common
behavior
of these
enzymes,
we believe
that
esterase
activity
is not
their function.
The mechanism
of action of the proteases in our assay is currently
under investigation.
No lipase activity
has been found in any of the
proteolytic
enzymes
investigated,
as glycerol
is not
released
from triglycerides
by these enzymes.
Thinlayer chromatography
(Figure 3) similarly
shows the
lack of activity
toward triglycerides
by a-chymotrypsin in the absence of lipase.
One of our major concerns
was the possibility
that
the
lipase-protease
combination
could
hydrolyze
phospholipids.
Under the conditions
of our assay, no
free glycerol
was formed from lecithin,
lysolecithin,
or indeed
from L-a-glycerol
phosphate.
We did not
investigate
whether
fatty acids are liberated
by our
hydrolyzing
enzymes
from these
compounds.
This
would be an important
consideration
if triglycerides
were determined
by assaying
free fatty acids produced, rather than glycerol.
Thin-layer
chromatography
was used to separate
and identify
the components
formed by the following
incubation
mixture:
serum
(0.5 ml) was incubated
for 30 mm at 30#{176}C
with 50 U of a-chymotrypsin
or
1300 U of lipase, or both enzymes
in 2 ml of potassium phosphate
buffer (0.1 mol/liter,
pH 7), or with
the complete
triglycerides
reagent.
The lipids were
extracted
from these
mixtures
and separated
by
thin-layer
chromatography
as described
(Figures
2-4). Esters of cholesterol
and of fatty acids are not
hydrolyzed
by the reagent
(Figure
4). Free fatty
acids were evident
after a very short period of interaction of the reagent
with serum
(Figure
4, C). At
this time the triglycerides
spot was very faint. After
10 mm, this spot had completely
disappeared.
Glycerol monooleate
and triglycerides
are not hydrolyzed
by chymotrypsin
alone,
but are rapidly
attacked
when lipase is added.
Hydrolysis
of triglycerides
is
complete
when both enzymes
are present;
the other
components
of the glycerol
reagent
are not needed
for the hydrolysis,
as shown in Figure 3.
S.:
S.
#{149}
I
S
#{149}
A
Fig.
phy
2. Standards
A, Cholesteryl
oleate;
separated
B. Methyl
E
F
by thin-layer
linolenate;
G
chromatogra-
C, Triolein;
D, Mixture
of all
standards;
II.
0
Fig. 3. Thin-layer
from serum lipids
A, Untreated
treated
without
pase
serum;
____
______
-.--
chromatography
of hydrolysis
,-&
4;#{149}r1
products
B, Standards
without methyl linolenate;
C, Serum
D, Serum treated with lipase; E. Standards
F, Serum treated with o-chymotrypsin
and Ii-
with a-chymotrypsin;
cholesteryl
oleate;
CLINICAL
CHEMISTRY,
1973
479
:t
#{248}.
S.
ii
#{149}0
I.
J_
.,.
,_.
A
-$t
#{149}-#{176}i
f
Fig. 4. Thin-layer chromatography
of hydrolysis products
from serum lipids after treatment with the total triglycerides reagent
.
6
T.
10 12 54 $6 1$ 20
1. MipuNs
6
Ti..
S 10 12 14 16 1$ 20
I. MI..tss
of the hydrolysis
mm is present,
as demonstrated
by the constant
rate
of decrease
in absorbance
of the system
before the
addition
of glycerol kinase (Figure 5, G), may be the
result
of the binding
of fatty acids to this protein
and thus to their solubilization
and removal from the
reactants.
This was the principal
reason for adding
this protein to the reagent.
The blank rate generated
in the assay is due to
phosphatases
acting
on PEP and ATP. The major
sources of these contaminants
are lipase, glycerol kinase, and possibly the sample itself.
The rate owing to contaminating
enzymes
or loss
in absorbance
caused by contaminating
substrates
in
the reagent
can be determined
for every batch by
performing
a blank assay with water in the place of
the sample.
Phosphate
ions are known, to inhibit
phosphatase
activity
(20), and their effect in reducing the activity
of the contaminants
in the reagent is
shown in Table 2. The pH chosen was 7, even though
the Table
indicates
that the phosphatase
activity
from the reagent
is somewhat
higher at this pH. On
the other hand,
it is important
to inhibit
alkaline
phosphatases
from serum,
which may have higher
activities
than those contaminating
the enzymes
of
the reagent.
Under these conditions,
and with this
buffer, increase
in blank rate caused by phosphatases in the sample
has not been observed
by us. Even
when purified
human intestinal
or placental
alkaline
phosphatase
was added to serum (2000 U per liter),
the increase
in blank rate of the system is negligible.
The average
increase
noted at this concentration
of
enzyme was less than 0.015 for 10 mm, equivalent
to
13 mg of triglycerides
per 100 ml under the conditions of our assay. However,
our experience
in the
application
of this method has not yet been so extensive as to rule out increase
in rate or inhibitors
from
sera in some pathological
conditions
or as a result of
a particular
medication.
In these cases, individual
Reagent at 30#{176}C
inhibition,
Buffer
pH
Av A/mIn
Tris-maleate
Tris-succinate
Tris-succinate
Potassium phosphate
7
7.6
8.0
8.0
0.089
0.0098
0.0016
0.0006
0
90
98
99
Potassium
Potassium
7.6
7.0
0.0015
0.002
98
97
phosphate
phosphate
AUTO
ANALYZER
100
200
300
400
500
600
700
PRESENT METHOD
correction
could be applied by taking a third absorbance reading 20 mm after addition
of glycerol kinase,
and subtracting
the xA between
10 and 20 mm from
that between
0 and 10 mm. Should
the blank rate
thus determined
be lower than that found with the
reagent
alone,
it would
indicate
a depletion
in
NADH or inhibition
of some of the enzymes
in the
system.
NADH may be depleted
at high concentrations of triglycerides
or as a result of high pyruvate
content
in the sample.
This last compound
may be
present in high concentration
in some control sera.
The triglycerides
reagent
was modified
according
to these considerations
and to the optimum
concentration
of the components
as determined
under the
conditions
of our assay. The reagent
as finally developed contained:
magnesium,
5 zmol; ATP, 0.9 zmol;
PEP, 0.9 mol;
bovine serum albumin,
5 mg; pyruvate kinase,
6 U; lactate
dehydrogenase,
2 U; R.
delemar
lipase,
400 U; a-chymotrypsin,
30 U;
NADH,
0.4 mg, all in a final volume of 3 ml in potassium
phosphate
buffer (pH 7, 0.1 mol/liter).
Standard
solutions
of glycerol can be used to provide a control for the reagent.
A solution
containing
1 g of triolein
in 100 ml of 2-propanol
can also be
used. Aliquots
of 5, 10, and 15 l of this solution
will
give a decrease
in absorbance
equivalent
to that obtained
by using 50 l of serum
containing,
respectively, 100, 200, and 300 mg triglycerides
in 100 ml.
This will serve as a control
for the hydrolyzing
enzymes as well as for the glycerol reagent.
We prefer
to use a serum control standardized
by assay of glycerol after alkaline
hydrolysis
or by the AutoAnalyzer
procedure.
Results
for 38 sera by the present
method
vs. the
AutoAnalyzer
procedure
(4) produced
a correlation
coefficient
(r) of 0.993 and a linear regression
of y =
1.048 x - 4 (Figure 6).
Three
serum
pools were assayed
on 10 different
days by the present
method.
The results
appear
in
Table 3.
Other methods
for determining
glycerol
liberated
in the hydrolysis
of triglycerides
are currently
under
investigation.
In general,
they are not as convenient
as the one presented
here because
in most cases additional
steps are required,
and they do not lend
themselves
as readily to the use of a single reagent.
Fig. 6. Triglycerides
assays of 38 serum
AutoAnalyzer and by present method
Figures
are in mg/100
samples
by
ml
104
97
95
102
101
151
153
156
151
155
276
274
273
273
278
91
155
273
100
162
282
95
160
278
94
154
274
97
100
103
158
157
158
278
271
271
106
104
103
102
104
159
155
159
155
157
271
275
265
273
273
95
151
290
95
101
101
151
153
151
285
275
276
103
155
153
156
160
274
271
273
261
102
98
102
Mean
98
159
275
108
160
273
104
102
100
151
156
154
290
280
278
100
156
275
SD
3.86
3.22
7.00
CV %
3.86
2.06
2.54
We thank
tions, sound
CHEMISTRY.
Vol.
19. No.5,
1973
sugges-
481
References
1. Carlson,
L. A., and Wadstrom,
L. B., Determination
ides in blood serum. Clin. Chim. Acta 4, 197 (1959).
2. Henry,
R. J., Clinical
Chemistry:
Principles
and
Hoeber, New York, N. Y., 1964, p 864.
of glycerTechnics,
3. Eggstein,
M., and Kreutz,
F. H., Eine neue Bestimmung
der
Neutralfette
in Blutserum
and Gewebe.
KIm. Wochenschr. 44,
262(1966).
4. Kessler,
G., and Lederer,
H., Fluorometric
measurement
of triglycerides.
In Automation
in Analytical
Chemistry,
Technicon
Symposia.
1965; L. T. Skeggs,
et al, Eds. Mediad,
New York,
N.Y., 1966,p341.
5. Rice, E. W., Triglycerides
(neutral
fat)
in serum.
Stand.
Methods Clin.Chem. 6,215(1970).
6. Soloni,
F. G., Simplified
manual
micromethod
tion of serum triglycerides.
Clin.Chem. 17,529(1971).
for determina-
482
CLINICAL
CHEMISTRY,
Vol.
19, No.5,
1973
quantitation
of plasma
neutral
lipids and free fatty acids. Clin.
Chem. 13,773(1967).
11. Laboureur,
P., and Labrousse,
M., Lipase de Rhizopus arrhizus. Obtention,
purification,
et proprietes
de Ia lipase de Rhizopus arrhizus var. delemar.
Bull. Soc. Chim. Biol. 48, 747 (1966).
12. Willis, E. D., Lipases. Advan.
Lipid Res. 3, 197 (1965).
13. Mattson,
triglycerides
F. H., and
by pancreatic
of
14. Mattson,
F. H., and Beck, L. W., The specificity
of pancreatic lipase for the primary
hydroxyl
groups
of glycerides.
J. Biol.
Chem. 219, 735(1956).
15. Mattson,
F. H., and Volpenheim,
R. A., Hydrolysis
of primary and secondary
esters
of glycerol
by pancreatic
juice. J.
Lipid Res. 9,79(1968).
16. Desnuelle,
P., Chymotrypsin.
In The Enzymes,
2nd ed., 4, P.
D. Boyer, H. Lardy, and K. Myrback,
Eds. Academic
Press, New
York, N. Y., 1960, pp 111 and 112.
17. Fukumoto,
J., Lwai, M., and Tsujisaka,
Y., Studies
on lipase.
IV. Purification
and properties
of a lipase secreted
by Rhizopus
delemar. J. Gen. Appl. Microbiol.
10, 257 (1964).
18. National
Formularv,
13th ed., American
Pharmaceutical
Association,
Washington,
D. C. 20037, p 747.
19. Brochure
on Pronase
by Kaken
Chemical
Co., Ltd.,
Japan. Distributed
by Calbiochem,
La Jolla, Calif. 92037.
Tokyo,
20. tadtman,
T. C., Alkaline
phosphatases.
In The Enzymes,
2nd ed., 5, P. D. Boyer, H. Lardy,
and K. Myrback,
Eds. Academic Press, New York, N. Y., 1960, p55.